Challenging Times in Lead Management: From Implant to Extraction or Abandonment
October 13, 2009
7:00 – 8:30 p.m. ET

The webcast covered topics related to lead implantation, extraction, and abandonment. The panelists fielded live questions from the audience to allow participants the opportunity to inquire about their concerns associated with lead management.

Did you miss the live event?
Archive webcast available! Watch the recorded webcast »

This program was supported by an educational grant from:

Faculty

• Andrew E. Epstein, MD, FHRS
  University of Pennsylvania Hospital
• Laurence M. Epstein, MD
  Brigham & Women's Hospital
• Paul A. Friedman, MD, FHRS
  Mayo Clinic

Intended Audience

This program is intended for a professional audience, including, but not limited to:

• Cardiologists
• Cardiothoracic and Vascular Surgeons
• Electrophysiologists
• Internists
• Interventionalists
• Fellows in Cardiovascular Diseases and Cardiothoracic Surgery
• Nurses/Nurse Practitioners/PAs

Challenging Times in Lead Management: From Implant to Extraction or Abandonment is part of the Heart Rhythm Society's SCA 360° Initiative.

Learning Objectives

Upon the conclusion of this program, participants will be able to:

• Create strategies for lead management when problems arise
• Predict how lead decisions at implant or revision may impact subsequent patient care
• Describe how to manage leads to ensure patient safety
• Recognize when to abandon and when to explant a lead
• Apply contemporary guidelines for lead extraction
• Recognize the Heart Rhythm Society consensus document recommendations on lead performance to guide patient management

Disclosure of Faculty's Commercial Relationship(s)

Faculty Disclosures (11K, PDF)

It is the policy of the Heart Rhythm Society to ensure balance, independent objectivity, and scientific rigor in all its sponsored educational programs. All faculty members participating in continuing medical education activities are required to disclose to the program audience any real or apparent conflict of interest related to the content of their presentations. In accordance with the ACCME's Standards for Commercial Support of Continuing Medical Education, all faculty and planning partners must disclose any financial relationship(s) or other relationship(s) held within the past 12 months. The Heart Rhythm Society implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.

Accreditation

The Heart Rhythm Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Continuing Medical Education (CME)

The Heart Rhythm Society designates this educational activity eligible for 2.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extend of their participation in the activity. The AMA has determined that physicians not licensed in the USA who participate in this CME activity are eligible for AMA PRA Category 1 Credits™.

Continuing Education (CE) for Nurses

The Heart Rhythm Society is an approved provider of continuing nursing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. It has been assigned code R3x-PRV-09-03. A maximum of 2.0 credit hours are available for this educational activity.

Disclaimer

This program provides a forum for the open exchange and discussion of research results and scientific advancements in the field of cardiovascular pacing and electrophysiology; however, the Society makes no representation or warranty as to the truth, originality, or accuracy of the information presented in this program or in materials distributed in connection with them. Nor are the views expressed by the individual speakers necessarily the views of the Society. The Heart Rhythm Society supports the ACCME’s policy on evidence-based content and encourages faculty to adhere to these standards when planning a presentation.

The views and opinions expressed by the participants in this program are their own, based upon their individual specific patient experiences or their general observations reacting to hypothetical circumstances. The views expressed and the statements made by participating physicians or allied professionals do not represent specific medical advice with respect to your patients nor do they represent any official policy or position taken by the Heart Rhythm Society.

Questions?

If you have questions about this program please contact Ashleigh Covington, Education Coordinator.

Lead Performance Panel Discussion from Heart Rhythm 2009

At the Heart Rhythm Society’s 2009 Annual Scientific Sessions, an expert panel of clinicians, industry, and the U.S. Food and Drug Administration convened to discuss the Recommendations from the Heart Rhythm Society Task Force on Lead Performance Policies and Guidelines clinical document (learn more). Listen to highlights from the interview:

• What the Society as an organization needs to do in the future regarding lead performance
  
• Keys to implementing the recommendations of the document and potential roadblocks
• The importance and role of benchmarks as outlined in the clinical document
• How this report has changed the physician's approach to patients
• The structure of changes in the FDA to monitor device performance
• The FDA approval process for post market study of leads
• The FDA's recommendation to develop a guidance document on what constitutes new and / or iteration of a device
• Helping those who are not coming into the EP clinic to get the devices they may need and concluding remarks

Panelists

N.A. Mark Estes, III, MD, FHRS
Mark D. Carlson, MD, FHRS
Robert G. Hauser, MD, FHRS
William H. Maisel, MD, FHRS
Megan Moynahan, MS

Copyright © 2009 Heart Rhythm Society.